UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases

Annals of oncology, 2007-12, Vol.18 (12), p.2030-2036

2007

Volltextzugriff (PDF)

Primary Chemotherapy for Operable Breast Cancer: Incidence and Prognostic Significance of Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery

Journal of clinical oncology, 2001-09, Vol.19 (18), p.3828-3835

2001

Volltextzugriff (PDF)

Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations

Journal of clinical oncology, 2000-12, Vol.18 (24), p.4053-4059

2000

Volltextzugriff (PDF)

Age as prognostic factor in premenopausal breast carcinoma

The Lancet (British edition), 1993-04, Vol.341 (8852), p.1039-1043

1993

Volltextzugriff (PDF)

Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction

Clinical cancer research, 2000-08, Vol.6 (8), p.3117-3122

2000

Volltextzugriff (PDF)

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin ± taxane-pretreated ovarian cancer patients

Annals of oncology, 2002-02, Vol.13 (2), p.258-266

2002

Volltextzugriff (PDF)

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical response

European journal of cancer (1990), 2003-05, Vol.39 (8), p.1089-1096

2003

Volltextzugriff (PDF)

Hepatic resection in metastatic breast cancer: results and prognostic factors

European journal of surgical oncology, 2000-03, Vol.26 (2), p.155-159

2000

Volltextzugriff (PDF)

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

British Journal of Cancer, 2000-12, Vol.83 (11), p.1480-1487

2000

Volltextzugriff (PDF)

Human papillomavirus genotype as a major determinant of the course of cervical cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2613-2619

1998

Volltextzugriff (PDF)

Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer

Annals of oncology, 1999-05, Vol.10 (5), p.553-560

1999

Volltextzugriff (PDF)

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6

European journal of cancer (1990), 1994, Vol.30 (5), p.645-652

1994

Volltextzugriff (PDF)

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients

Journal of clinical oncology, 1998-12, Vol.16 (12), p.3736-3743

1998

Volltextzugriff (PDF)

Outbreak of Clostridium difficile -related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics

The Journal of hospital infection, 2003-03, Vol.53 (3), p.187-192

2003

Volltextzugriff (PDF)

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Journal of clinical oncology, 2003-03, Vol.21 (6), p.968-975

2003

Volltextzugriff (PDF)

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer

British journal of cancer, 2003-08, Vol.89 (3), p.539-545

2003

Volltextzugriff (PDF)

Contralateral breast cancer: annual incidence and risk parameters

Journal of clinical oncology, 1995-07, Vol.13 (7), p.1578-1583

1995

Volltextzugriff (PDF)

Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines

Cancer treatment reviews, 2004-11, Vol.30 (7), p.643-650

Pouillart, Pierre

2004

Volltextzugriff (PDF)

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study

Journal of clinical oncology, 1996-05, Vol.14 (5), p.1697-1703

1996

Volltextzugriff (PDF)

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

European journal of cancer (1990), 1995-11, Vol.31 (12), p.1969-1975

1995

Volltextzugriff (PDF)

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer : toxicity and response (PEGASE 02 trial)

British journal of cancer, 1999-10, Vol.81 (3), p.449-456

1999

Volltextzugriff (PDF)

Randomized Parallel Study of Doxorubicin Plus Paclitaxel and Doxorubicin Plus Cyclophosphamide As Neoadjuvant Treatment of Patients With Breast Cancer

Journal of clinical oncology, 2004-12, Vol.22 (24), p.4958-4965

2004

Volltextzugriff (PDF)

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer

Journal of clinical oncology, 1994-09, Vol.12 (9), p.1764-1770

1994

Volltextzugriff (PDF)

Multicenter phase II–III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients

Annals of oncology, 2001-10, Vol.12 (10), p.1411-1415

2001

Volltextzugriff (PDF)

ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

European journal of cancer (1990), 2000-03, Vol.36 (5), p.586-591

2000

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(130)

Erscheinungsjahr

n.n

Thema

Humans
(130)
Middle Aged
(112)
Female
(110)
Aged
(85)
Life Sciences & Biomedicine
(78)
Science & Technology
(78)
Biological And Medical Sciences
(67)
Medical Sciences
(67)
Oncology
(65)
Male
(53)
Breast Neoplasms - Drug Therapy
(35)
Adolescent
(32)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(31)
Prognosis
(31)
Pharmacology. Drug Treatments
(30)
Tumors
(26)
Antineoplastic Agents
(25)
Breast Neoplasms - Pathology
(25)
Chemotherapy
(25)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases

Primary Chemotherapy for Operable Breast Cancer: Incidence and Prognostic Significance of Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery

Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations

Age as prognostic factor in premenopausal breast carcinoma

Detection of MUC1-expressing Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients by Real-Time Polymerase Chain Reaction

Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin ± taxane-pretreated ovarian cancer patients

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer: the role of clinical response

Hepatic resection in metastatic breast cancer: results and prognostic factors

Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer

Human papillomavirus genotype as a major determinant of the course of cervical cancer

Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients

Outbreak of Clostridium difficile -related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

Clinical significance of proliferative potential of occult metastatic cells in bone marrow of patients with breast cancer

Contralateral breast cancer: annual incidence and risk parameters

Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study

Breast tumour response to primary chemotherapy predicts local and distant control as well as survival

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer : toxicity and response (PEGASE 02 trial)

Randomized Parallel Study of Doxorubicin Plus Paclitaxel and Doxorubicin Plus Cyclophosphamide As Neoadjuvant Treatment of Patients With Breast Cancer

Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer

Multicenter phase II–III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients

ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

Aktive Filter

Suchergebnisse filtern